Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Profound autoimmune hemolysis and Evans syndrome in two asplenic patients with babesiosis.

Shatzel JJ, Donohoe K, Chu NQ, Garratty G, Mody K, Bengtson EM, Dunbar NM.

Transfusion. 2015 Mar;55(3):661-5. doi: 10.1111/trf.12901. Epub 2014 Oct 29.

PMID:
25354478
3.

How we investigate drug-induced immune hemolytic anemia.

Leger RM, Arndt PA, Garratty G.

Immunohematology. 2014;30(2):85-94. Review.

PMID:
25247618
4.

Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor.

Haley KM, Russell TB, Boshkov L, Leger RM, Garratty G, Recht M, Nazemi KJ.

J Blood Med. 2014 May 15;5:55-8. doi: 10.2147/JBM.S59192. eCollection 2014.

5.

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, de Haas M, Hyland C, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T.

Vox Sang. 2014 Jul;107(1):90-6. doi: 10.1111/vox.12127. Epub 2013 Dec 27.

6.

Use of monoclonal antibodies for preparing human immunoglobulin M-coated red blood cells.

Arndt PA, Garratty G.

Transfusion. 2013 Apr;53(4):923-4. doi: 10.1111/trf.12151. No abstract available.

PMID:
23565998
7.

Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families.

Pate LL, Myers JC, Palma JP, Viele M, Galel SA, Ferrer Z, Gonzalez CL, Benitz WE, Garratty G, Fontaine MJ.

Transfusion. 2013 Oct;53(10):2152-7. doi: 10.1111/trf.12027. Epub 2012 Dec 12.

8.

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents.

Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P.

Expert Opin Drug Deliv. 2012 Nov;9(11):1319-23. doi: 10.1517/17425247.2012.720969. Epub 2012 Aug 30.

PMID:
22931049
9.

Commentary. Re: Sudden onset of severe anemia in a patient with cystic fibrosis.

Garratty G.

Clin Chem. 2012 Sep;58(9):1290-1. doi: 10.1373/clinchem.2011.174169. No abstract available.

10.

Immune hemolytic anemia caused by drugs.

Garratty G.

Expert Opin Drug Saf. 2012 Jul;11(4):635-42. doi: 10.1517/14740338.2012.678832. Epub 2012 Apr 16. Review.

PMID:
22502777
11.

What do we mean by "Hyperhaemolysis" and what is the cause?

Garratty G.

Transfus Med. 2012 Apr;22(2):77-9. doi: 10.1111/j.1365-3148.2012.01151.x. Review. No abstract available. Erratum in: Transfus Med. 2012 Jun;22(3):239.

PMID:
22432977
12.

Patrick Loudon Mollison.

Garratty G.

Transfusion. 2012 Mar;52(3):684-5. doi: 10.1111/j.1537-2995.2012.03586.x. No abstract available.

PMID:
22404516
13.

Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.

Arndt PA, Leger RM, Garratty G.

Transfusion. 2012 Mar;52(3):602-12. doi: 10.1111/j.1537-2995.2011.03321.x. Epub 2011 Aug 31.

PMID:
21880048
14.

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report.

Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, Francis CL, Moulds JM, Moulds JJ, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Smart E, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T.

Vox Sang. 2011 Jul;101(1):77-82. doi: 10.1111/j.1423-0410.2010.01462.x. Epub 2011 Mar 14. No abstract available. Erratum in: Vox Sang. 2012 Apr;102(3):274.

15.

Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors.

Leger RM, Garratty G.

Transfusion. 2011 Aug;51(8):1740-4. doi: 10.1111/j.1537-2995.2010.03040.x. Epub 2011 Feb 8.

PMID:
21303372
16.

Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole.

Arndt PA, Garratty G, Wolf CF, Rivera M.

Transfus Med. 2011 Jun;21(3):194-8. doi: 10.1111/j.1365-3148.2010.01061.x. Epub 2010 Dec 22.

PMID:
21175904
17.

A new section, "blood group genomics," with a new associate editor.

Garratty G, Ness PM.

Transfusion. 2010 Dec;50(12):2528. doi: 10.1111/j.1537-2995.2010.02923.x. No abstract available.

PMID:
21126248
18.

A severe case of cefoxitin-induced immune hemolytic anemia.

Leaf DE, Langer NB, Markowski M, Garratty G, Diuguid DL.

Acta Haematol. 2010;124(4):197-9. doi: 10.1159/000320169. Epub 2010 Nov 2.

PMID:
21042010
19.
20.

Immune hemolytic anemia associated with drug therapy.

Garratty G.

Blood Rev. 2010 Jul-Sep;24(4-5):143-50. doi: 10.1016/j.blre.2010.06.004. Epub 2010 Jul 21. Review.

PMID:
20650555
21.

Advances in red blood cell immunology 1960 to 2009.

Garratty G.

Transfusion. 2010 Mar;50(3):526-35. doi: 10.1111/j.1537-2995.2009.02493.x. Review. No abstract available.

PMID:
20609200
22.

Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.

Bandara M, Seder DB, Garratty G, Leger RM, Zuckerman JB.

Case Rep Med. 2010;2010:161454. doi: 10.1155/2010/161454. Epub 2010 Jun 2.

23.

Increased all-cause and cancer mortality in HTLV-II infection.

Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL; HTLV Outcomes Study.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):290-6. doi: 10.1097/QAI.0b013e3181cc5481.

24.

Drug-induced immune hemolytic anemia.

Garratty G.

Clin Adv Hematol Oncol. 2010 Feb;8(2):98-101. No abstract available.

PMID:
20386530
25.

A new mechanism for immune destruction of red blood cells?

Garratty G.

Transfusion. 2010 Feb;50(2):274-7. doi: 10.1111/j.1537-2995.2009.02564.x. Epub 2010 Jan 15. No abstract available.

PMID:
20088838
26.

Drug-induced immune hemolytic anemia.

Garratty G.

Hematology Am Soc Hematol Educ Program. 2009:73-9. doi: 10.1182/asheducation-2009.1.73. Review.

PMID:
20008184
27.

Clinical evaluation for lymphoproliferative disease prompted by finding of IgM warm autoanti-IT in two cases.

Leger RM, Lowder F, Dungo MC, Chen W, Mason HM, Garratty G.

Immunohematology. 2009;25(2):60-2.

PMID:
19927621
28.

Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody.

Arndt PA, Garratty G, Brasfield FM, Vemuri SL, Asuncion DJ.

Transfusion. 2010 Feb;50(2):302-7. doi: 10.1111/j.1537-2995.2009.02447.x. Epub 2009 Oct 23.

PMID:
19874564
29.

Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

Biswas HH, Engstrom JW, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL.

Neurology. 2009 Sep 8;73(10):781-9. doi: 10.1212/WNL.0b013e3181b6bba9.

30.

What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?

Garratty G.

Transfusion. 2009 Jun;49(6):1026-31. doi: 10.1111/j.1537-2995.2009.02216.x. No abstract available. Erratum in: Transfusion. 2009 Aug;49(8):1774.

PMID:
19638151
31.

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.

Arndt P, Garratty G, Isaak E, Bolger M, Lu Q.

Transfusion. 2009 Apr;49(4):711-8. doi: 10.1111/j.1537-2995.2008.02028.x. Epub 2009 Dec 15.

PMID:
19192254
32.

International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report.

Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke M, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T; International Society of Blood Transfusion Committee on Terminology for Red Blood Cell Surface Antigens.

Vox Sang. 2009 Feb;96(2):153-6. doi: 10.1111/j.1423-0410.2008.01133.x. No abstract available.

PMID:
19152607
33.

The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?

Garratty G.

Transfus Med. 2008 Dec;18(6):321-34. doi: 10.1111/j.1365-3148.2008.00891.x.

PMID:
19140815
34.

Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.

Arndt PA, Leger RM, Garratty G.

Transfusion. 2009 Feb;49(2):235-42. doi: 10.1111/j.1537-2995.2008.01957.x. Epub 2008 Oct 28.

PMID:
18980619
35.

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

Goodrich RP, Murthy KK, Doane SK, Fitzpatrick CN, Morrow LS, Arndt PA, Reddy HL, Buytaert-Hoefen KA, Garratty G.

Transfusion. 2009 Jan;49(1):64-74. doi: 10.1111/j.1537-2995.2008.01940.x. Epub 2008 Oct 14.

PMID:
18954398
36.

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.

Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL; HTLV Outcomes Study (HOST) Investigators.

Blood. 2008 Nov 15;112(10):3995-4002. doi: 10.1182/blood-2008-05-155960. Epub 2008 Aug 28.

37.

Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.

Blackall DP, Pesek GD, Montgomery MM, Oza KK, Arndt PA, Garratty G, Shahcheraghi A, Denomme GA.

Am J Perinatol. 2008 Oct;25(9):541-5. doi: 10.1055/s-0028-1085072. Epub 2008 Aug 21.

PMID:
18720327
38.

Serological studies of piperacillin antibodies.

Leger RM, Arndt PA, Garratty G.

Transfusion. 2008 Nov;48(11):2429-34. doi: 10.1111/j.1537-2995.2008.01852.x. Epub 2008 Jul 22.

PMID:
18657075
39.

Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.

Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL.

J Infect Dis. 2008 Aug 15;198(4):609-13. doi: 10.1086/590159.

PMID:
18588482
40.

An update on drug-induced immune hemolytic anemia.

Garratty G, Arndt PA.

Immunohematology. 2007;23(3):105-19. No abstract available.

PMID:
18284300
41.

2008 Immunohematology Reference Laboratory Conference. Summary of presentations.

Quinley ED, Garratty G, Heflin T, Cummings E, Hamilton JR, Arndt PA.

Immunohematology. 2008;24(2):62-71. No abstract available.

PMID:
19852133
42.

Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion.

Garratty G.

Vox Sang. 2008 Feb;94(2):87-95. Epub 2007 Nov 22. Review.

PMID:
18034787
43.

Factors influencing donor return.

Schlumpf KS, Glynn SA, Schreiber GB, Wright DJ, Randolph Steele W, Tu Y, Hermansen S, Higgins MJ, Garratty G, Murphy EL; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.

Transfusion. 2008 Feb;48(2):264-72. Epub 2007 Nov 13.

PMID:
18005325
44.

Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.

Garratty G, Petz LD.

Br J Haematol. 2007 Nov;139(4):622-3. No abstract available.

PMID:
17979948
45.

role of altruistic behavior, empathetic concern, and social responsibility motivation in blood donation behavior.

Steele WR, Schreiber GB, Guiltinan A, Nass C, Glynn SA, Wright DJ, Kessler D, Schlumpf KS, Tu Y, Smith JW, Garratty G; Retrovirus Epidemiology Donor Study.

Transfusion. 2008 Jan;48(1):43-54. Epub 2007 Sep 24.

PMID:
17894795
46.

Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria.

Koppel A, Lim S, Osby M, Garratty G, Goldfinger D.

Transfusion. 2007 Oct;47(10):1902-4.

PMID:
17880618
47.

Where are we, and where are we going, with DNA-based approaches in immunohematology? Is serology finished?

Garratty G.

Transfusion. 2007 Jul;47(1 Suppl):1S-2S. No abstract available.

PMID:
17593278
48.

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.

Armstrong JK, Hempel G, Koling S, Chan LS, Fisher T, Meiselman HJ, Garratty G.

Cancer. 2007 Jul 1;110(1):103-11.

49.

A reminder that ZZAP reagent removes complement in addition to IgG from coated RBCs.

Leger RM, Garratty G.

Immunohematology. 2006;22(4):205-6. No abstract available.

PMID:
17436477
50.

International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report.

Daniels G, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke MA, Poole J, Reid ME, Rouger P, van der Schoot CE, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff CM, Zelinski T.

Vox Sang. 2007 Apr;92(3):250-3. No abstract available.

PMID:
17348875

Supplemental Content

Loading ...
Support Center